Transforming Diabetes Care with Data and AI | SGInnovate
May272019

Location

SGInnovate
32 Carpenter Street
Singapore 059911

Transforming Diabetes Care with Data and AI

Presented by General Assembly
Partnered with SGInnovate

Great transformation and innovation happen when entrepreneurs and industry innovators work together. Join us for a panel discussion with digital health entrepreneurs and innovators. Our panellists will discuss how data and AI can be used to create a better future for those living with diabetes and explore opportunities where startups and relevant industries can work together to make that future a reality.

Date: 27 May 2019, Monday
Time: 6:30pm – 9:00pm 
Venue: 32 Carpenter Street, Singapore 059911 

Programme Details:
6:30pm – 7:00pm: Check-in & Networking
7:00pm – 8:15pm: Panel Discussion and Q&A
8:15pm – 9:00pm: Networking

Speakers:

  • Dr Yau Teng Yan, Chief Medical Officer, Holmusk
  • Dario Heymann, Chief Research Officer, Galen Growth Asia

Speaker's Profiles:

Dr Yau Teng Yan, Chief Medical Officer, Holmusk

Dr Yau Teng Yan. MBBS, MMed, FRCR Photo

Dr Yau Teng Yan (MBBS, M.Med, FRCR) is the Chief Medical Officer at Holmusk, a healthcare company that leverages technology and data science to deliver effective, engaging and scalable digital programmes for people living with chronic diseases like diabetes. His current work also includes a grant from the Ministry of Health on a technology-driven intervention programme for dementia prevention, and with the Health Promotion Board on a digital health coaching intervention for overweight & obese children.

Prior to Holmusk, Teng Yan was a practicing doctor for 7 years in several public hospitals in Singapore including Tan Tock Seng Hospital and Singapore General Hospital. He trained in diagnostic radiology and is a fellow of the Royal College of Radiologists (London). He has also worked at the Military Medicine Institute where he was involved in health policy decisions and health screening initiatives in the Singapore Armed Forces. He is a big believer that technology and artificial intelligence will transform the delivery of healthcare, to achieve better outcomes, reduced costs and improved patient experience.

Dario Heymann, Chief Research Officer, Galen Growth Asia

Dario Heymann Photo

Dario is the Chief Research Offer of Galen Growth Asia. He joined in 2016 as the founding Research Manager where he supported the building of HealthTech Alpha; Asia’s only database and analytics platform dedicated to HealthTech ventures. HealthTech Alpha, remains the only database and analytics provider for digital health in Asia, delivering accurate and regularly curated information to investors, industry innovation leaders, startups CxOs, and researchers.

Since 2018, he is acting as Chief Research Offer, managing the database and the research engagement with clients, such as Pharmaco, insurance companies, investors and tech companies. Besides overseeing and managing the development of the analytic platform, Dario is also responsible for the overall research and market intelligence of the HealthTech ecosystem in Asia which helps inform and improve organisations’ overall strategy by grounding decisions in real-world evidence and analysis. Dario helps organisations grow by providing insights and comprehensive sources, vital to monitor the pulse of the ecosystem and accelerate business strategies.

Prior to Galen Growth Asia, Dario has worked in drug discovery, mainly for the development of novel drugs in oncology, both in pharma and academia in Singapore, China and Germany. Apart from building Galen Growth Asia, Dario is pursuing his doctorate in Material Science and Engineering, where he works on novel biodegradable materials that can be used for prosthesis. Dario holds Masters in Material Science & Engineering, Biochemistry, and Molecular Biology.

Topics: MedTech / HealthTech / BioTech

You may also like the following: